Conference Description
The Extracellular Vesicles GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes an array of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
Understanding the modes and mechanisms in the biology of Extracellular Vesicles (EV) and putting them in the context of physiological and pathological processes in mammalian organisms is essential for their biomedical utilization. EVs may have a huge clinical potential either in biomarker discovery as precise tools for disease monitoring or as EV-based drug candidates being able to modify disease courses. Currently, the lack of a comprehensive knowledge regarding EV biology in health and disease hampers a swift development of potency assays that would be needed in preclinical studies and in the course of clinical assessment.
Confirming the relevance and predictive strength of EV-based disease specific biomarkers on the one hand side as well as the development of disease relevant in vitro and in vivo potency assays to eveluate the therapeutic potential will benefit from a collaborative approach covering broad expertise. This Gordon Research Conference aims to connect expert views from basic discovery providing deep mechanistic insights with the awareness of requirements of biomedical development either in biomarker or therapeutics development. The presentation of cutting-edge technologies providing novel ideas for biomarker discovery or tools for EV-therapeutics manufacturing, bioprocessing and control will be accompanied by a discussion of regulatory aspects as well as specific patient needs in clinical development.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by April 11, 2026. Please check back for updates.
Keynote Session: EV-Based Biomarkers and Therapies: Identifying Molecular Mechanisms
Discussion Leaders
Speakers
Novel Concepts for EV-Based Therapeutics
Discussion Leaders
Speakers
EVs as Promising Tools in Biomarker Discovery
Discussion Leaders
Speakers
In-vitro and In-vivo Model-Systems for EV Characterization
Discussion Leaders
Speakers
Towards EV-Potency Assay Development
Discussion Leaders
Speakers
Meet the Hurdle: Regulatory Aspects in EV Therapeutics Development
Discussion Leaders
Speakers
Utilizing EVs in Biomedical Applications
Discussion Leaders
Speakers
Exploiting EV Biology and Functions for Therapeutics or Diagnostics
Discussion Leaders
Speakers
Ongoing Clinical Studies Investigating EV-Based Therapeutics and Initial Results
Discussion Leaders
Speakers
